ACLS Pretest Question Answers (Pharmacology) 2024

ACLS Pretest Question Answers (Pharmacology) 2024: Explore our comprehensive guide for the American Heart Association’s ACLS Pharmacology Pre-Test Questions and Answers. This resource provides detailed explanations and insights to help healthcare professionals prepare effectively for the ACLS certification.

Stay updated with the latest protocols and drug information essential for life-saving cardiac care. Ideal for medical students, nurses, and emergency responders seeking to enhance their pharmacology knowledge in line with AHA guidelines.

ACLS Pretest Question Answers

Test Name ACLS Pretest
Type of Question Multiple Choice Question Answers
Subject Pharmacology
Total Question 10
Test Type Sample / Mock Test
Editable & Printable PDF / Doc YES (Download link is given below)
Available of Answers YES
ACLS Cardiac Life Support Exam

Q1. Which of the following is most accurate regarding administering vasopressin during cardiac arrest?

  • A. Vasopressin is indicated for VF and pulseless VT prior to the delivery of the first shock
  • B. The correct dose of Vasopressin is 40 U administered IV or IO
  • C. Vasopressin is recommended instead of epinephrine for the treatment of asystole
  • D. Vasopressin can be administered twice during cardiac arrest
Show Answers
Answer: B. The correct dose of Vasopressin is 40 U administered IV or IO

Q2. Your patient has been intubated. IV/IO access is not available. Which combination of drugs can be administered by the endotracheal route of administration?

  • A. Amiodarone, lidocaine, epinephrine
  • B. Epinephrine, vasopressin, amiodarone
  • C. Lidocaine, epinephrine, vasopressin
  • D. Vasopressin, amiodarone, lidocaine
Show Answers
Answer: C. Lidocaine, epinephrine, vasopressin

Q3. Which of the following statements about the use of magnesium in cardiac arrest is most accurate?

  • A. Magnesium is indicated for VF/pulseless VT associated with torsades de pointes
  • B. Magnesium is indicated for shock-refractory monomorphic VT
  • C. Magnesium is contraindicated in VT associated with a normal QT interval
  • D. Magnesium is indicated for VF refractory to shock and amiodarone or lidocaine.
Show Answers
Answer: A. Magnesium is indicated for VF/pulseless VT associated with torsades de pointes

Q4. A patient with a possible acute coronary syndrome has ongoing chest discomfort unresponsive to 3 sublingual nitroglycerine tablets. There are no contraindications and 4 mg of morphine sulfate was administered. Shortly, BP falls to 88/60 and the patient complains of increased chest discomfort. You would:

  • A. Give an additional 2 mg of morphine sulfate
  • B. Start dopamine at 2 ụg/kg per minute and titrate to BP 100 systolic.
  • C. Give nitroglycerin 0.4 mg sublingually
  • D. Give normal saline 250 mL to 500 mL fluid bolus
Show Answers
Answer: D. Give normal saline 250 mL to 500 mL fluid bolus

Q5. A patient has a rapid irregular wide-complex tachycardia. The ventricular rate is 138. He is asymptomatic with a BP of 110/7-. He has a history of angina. Which of the following actions is recommended?

  • A. Give lidocaine 1-1.5 mg IV bolus
  • B. Immediate synchronized cardioversion
  • C. Seek expert consultation
  • D. Give adenosine 6 mg IV bolus
Show Answers
Answer: C. Seek expert consultation

Q6. A 62-year-old man suddenly began to experience difficulty speaking and left-sided weakness. He is brought to the ER. He meets initial criteria for fibrinolytic therapy and a CT scan of the brain is ordered. Guidelines for antiplatelet and antithrombotic therapy are:

  • A. Administer heparin if CT scan is negative for hemorrhage
  • B. Give aspirin 160 mg and clopidogrel 75 mg orally
  • C Administer aspirin 160-325 mg orally chewed, immediately
  • D. Do not give aspirin for at least 24 hours if tPA is administered
Show Answers
Answer: D. Do not give aspirin for at least 24 hours if tPA is administered

Q7. A patient is in cardiac arrest. VFib has been refractory to an initial shock. Two attempts at peripheral IV have been unsuccessful. The next recommended access route of administration for the delivery of drugs during CPR is:

  • A. External jugular vein
  • B. Femoral vein
  • C. Intraosseous
  • D. Endotracheal
Show Answers
Answer: C. ntraosseous

Q8. A patient with an ST-segment elevation MI has ongoing chest discomfort. Fibrinolytic therapy has been ordered. Heparin 4000 U IV bolus was administered and a heparin infusion 100 U per hour is being administered, and Aspirin was not taken by the patient because he had a history of gastritis treated 5 years ago. Your next action is to:

  • A. Substitute clopidogrel 300 mg loading dose
  • B. Give aspirin 160 – 325 mg chewed, immediately
  • C. Give 75 mg enteric-coated aspirin only
  • D. Give 325 mg enteric-coated aspiring rectally
Show Answers
Answer: A. Substitute clopidogrel 300 mg loading dose

Q9. A patient with possible ACS and a bradycardia of 42/min has ongoing chest discomfort. What is the initial dose of atropine?

  • A. Atropine 0.5 mg
  • B. Atropine 1.0 mg
  • C. Atropine 0.1 mg
  • D. Atropine 3 mg
Show Answers
Answer: A. Atropine 0.5 mg

10. A patient is in cardiac arrest. VFib has been refractory to an initial shock. Of the following, which drug and dose should be administered first by IV/IO route?

  • A. Atropine 1 mg
  • B. Epinephrine 1 mg
  • C. Vasopressin 20 U
  • D. Sodium bicarbonate 50 mEq
Show Answers
Answer: B. Epinephrine 1 mg

Q11. A 35-year old woman has palpitations, lightheadedness, and a stable tachycardia. The monitor shows a
regular narrow-complex QRS at a rate of 180/min. Vagal maneuvers have not been effective in terminating
the rhythm. An IV has been established. What drug should be administered IV?

  • A. Epinephrine 2-10 ụg/kg per minute
  • B. Atropine 0.5 mg
  • C. Lidocaine 1 mg/kg
  • D. Adenosine 6 mg
Show Answers
Answer: D. Adenosine 6 mg

Q12. A patient with a possible ST-segment elevation MI has ongoing chest discomfort. Which of the following
would be a contraindication for administration of nitrates?

  • A. HR of 90/min
  • B. BP > 180 systolic
  • C. Use of phosphodiesterase inhibitor within 12 hours
  • D. Left ventricular infarct with bilateral rales
Show Answers
Answer: C. Use of phosphodiesterase inhibitor within 12 hours

Q13. A patient has sinus bradycardia with a rate of 36/min. Atropine has been administered to a total dose of 3
mg. TCP has failed to capture. The patient is confused and BP is 100/60. Which of the following is now
indicated?

  • A. give additional 1mg Atropine
  • B. Give NS bolus 250 mL-500mL
  • C. Start dopamine 10-20 ụg/kg per minute
  • D. Start epinephrine 2-10 ụg/min
Show Answers
Answer: D. Start epinephrine 2-10 ụg/min

Q14. A patient is in pulseless VTach. Two shocks and one dose of epinephrine have been given. The next
drug/dose to anticipate to administer is:

  • A. Amiodarone 300 mg
  • B. Amiodarone 150 mg
  • C. Lidocaine 0.5 mg/kg
  • D. Epinephrine 3 mg
Show Answers
Answer: A. Amiodarone 300 mg

Q15. A patient is in refractory VFib and has received multiple appropriate defibrillations, epinephrine 1 mg IV twice, and an initial dose of lidocaine IV. The patient is intubated. A second dose of lidocaine is now called for. The recommended second dose of lidocaine is:

  • A. 0.5-0.75 mg/kg IV push
  • B. 2-3 mg/kg IV push
  • C. Give endotracheal dose 2-4 mg/kg
  • D. 1 mg/kg IV push
Show Answers
Answer: A. 0.5-0.75 mg/kg IV push 

Q16. You arrive on-scene with the Code Team. High-quality CPR is in progress. An AED has previously advised “no shock indicated”. A rhythm now finds asystole. The next action you would take is to:

  • A. place a Combitube or Laryngeal Mask Airway (LMA)
  • B. Attempt intubation with minimal CPR interruption
  • C. Call for a pulse check
  • D. Place IV or IO access
Show Answers
Answer: D. Place IV or IO access

Q17. Which of the following is most accurate regarding the administration of vasopressin during cardiac arrest?

  • A. Vasopressin is indicated for VF and pulseless VT prior to the delivery of the first shock
  • B. Vasopressin can be administered twice during cardiac arrest
  • C. Vasopressin is recommended instead of epinephrine for the treatment of asystole
  • D. The correct dose of Vasopressin is 40 U administered IV or IO
Show Answers
Answer: D. The correct dose of Vasopressin is 40 U administered IV or IO

Q18. A patient is in cardiac arrest. High-quality chest compression are being given. The patient is intubated and an IV has been established. The rhythm is asystole. The first drug/dose to administer is:

  • A. Epinephrine 1 mg or Vasopressin 40 U IV or IO
  • B. Epinephrine 3 mg via ETT
  • C. Dopamine 2 to 20 ụg/kg per minute IV or IO
  • D. Atropine 1 mg IV or IO
Show Answers
Answer: A. Epinephrine 1 mg or Vasopressin 40 U IV or IO

Q19. A 57 year-old woman has palpitations, chest discomfort and tachycardia. The monitor shows a regular wide-complex QRS at a rate of 180.min. She becomes diaphoretic and BP is 80/60. The next action is to:

  • A. Obtain 12 lead ECG
  • B. Perform immediate synchronized cardioversion
  • C. Establish IV and give sedation for electrical cardioversion
  • D. Give amiodarone 300 mg IV push
Show Answers
Answer: B. Perform immediate synchronized cardioversion

Q20. A patient is in refractory VFib. High-quality CPR is in progress and shocks have been given. One dose of epinephrine was given after the second shock. An antiarrhythmic drug was given immediately after the third shock. What drug should the team leader request to be prepared for administration?

  • A. Repeat the antiarrhythmic
  • B. Escalating dose epinephrine 3 mg
  • C. Second dose of epinephrine 1 mg
  • D. Sodium bicarbonate 50 mEq
Show Answers
Answer: C. Second dose of epinephrine 1 mg

See also: